市場調査レポート
商品コード
1378994
人工授精市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測Artificial Insemination Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
人工授精市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測 |
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2~3営業日
|
世界の人工授精市場規模は2022年に20億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに32億米ドルに達し、2022年から2028年の間に8.1%の成長率(CAGR)を示すと予測しています。不妊率の増加、ライフスタイルの急速な変化、病状の蔓延が市場を牽引する主な要因のひとつです。
人工授精は、医療処置によって精子を女性の生殖器官に直接入れる受精プロセスです。通常、新鮮精子または凍結精子を使用し、頸管内、子宮内、膣内などさまざまな方法で行われます。人工授精の構成要素には、精液の採取、精液の処理、精液の設置が含まれます。人工授精は、妊娠の確率を高め、性感染症(STI)のリスクを軽減し、男性不妊の場合にはドナーの精子を使用することができます。さらに、体外受精(IVF)と比較して、人工授精は低侵襲(MI)で費用対効果が高いです。現在、人工授精には主に同種と異種の2種類があります。同種人工授精では男性パートナーの精子を用いて女性パートナーの卵子を受精させるが、異種人工授精ではドナーの精子を用いて女性パートナーの卵子を受精させる。
不妊率の増加と生殖補助医療(ART)の必要性は、市場成長を後押しする主な要因の一つです。ライフスタイルの急速な変化や、多嚢胞性卵巣症候群(PCOS)や子宮内膜症などの病状の蔓延が人工授精の需要を急増させ、市場の成長をさらに加速させています。これはさらに、新興国での人工授精の受け入れと利用しやすさの向上にも支えられています。さらに、精子と卵子の選別、凍結保存、着床前遺伝子検査のための改良技術の開発など、さまざまな技術の進歩が市場成長を促進しています。このほか、ドナー精子やドナー卵子の入手可能性、同性婚やLGBTによる子育ての人気の高まり、ヘルスケア・インフラの改善なども市場成長を促進する要因として期待されています。さらに、有利な規制の存在、不妊症や人工授精に関する認識や教育キャンペーンの高まり、個別化・カスタマイズされた人工授精の需要の高まりなどが、市場成長を後押ししています。その他、人工授精サービスを提供するクリニックやヘルスケア施設の増加、人工授精処置に保険が適用されること、出産を遅らせてキャリア目標を追求する傾向が高まっていることなどが、市場成長を積極的に後押ししています。
The global artificial insemination market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2022-2028. Increasing infertility rates, rapid lifestyle changes, and escalating prevalence of medical conditions represent some of the key factors driving the market.
Artificial insemination is a process of fertilization that involves the placement of sperm directly into the female reproductive system through medical procedures. It typically involves the use of either fresh or frozen sperm and can be done in a variety of ways, including intracervical, intrauterine, or intravaginal methods. The components of artificial insemination include semen collection, semen processing, and semen placement. Artificial insemination offers increased chances of conception, reduced risk of sexually transmitted infections (STIs), and the ability to use donor sperm in cases of male infertility. Additionally, as compared to in vitro fertilization (IVF), artificial insemination is minimally invasive (MI) and cost-effective. Currently, there are two primary types of the procedure, including homologous and heterologous. Homologous insemination involves using the male partner's sperm to fertilize the female partner's egg, while heterologous insemination involves using donor sperm to fertilize the female partner's egg.
The increasing infertility rates and the need for assisted reproductive technologies (ART) are some of the key factors boosting the market growth. The rapid lifestyle changes and escalating prevalence of medical conditions, such as polycystic ovary syndrome (PCOS) and endometriosis, have surged the demand for artificial insemination procedures, further accelerating the market growth. This is further supported by the growing acceptance and accessibility of artificial insemination in emerging economies. Moreover, various technological advancements, such as the development of improved techniques for sperm and egg selection, cryopreservation, and pre-implantation genetic testing, are propelling the market growth. Besides this, the availability of donor sperm and donor eggs, the rising popularity of same-sex marriage and LGBT parenting, and the improving healthcare infrastructure are factors expected to drive the market growth. Furthermore, the presence of favorable regulations, the growing awareness and education campaigns about infertility and artificial insemination, and the escalating demand for personalized and customized artificial insemination procedures are fueling the market growth. Other factors, such as the increasing number of clinics and healthcare facilities offering artificial insemination services, the availability of insurance coverage for the procedure, and the surging trend of delaying childbirth and pursuing career goals, are positively supporting the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial insemination market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, source type and end use.
Intrauterine
Intracervical
Intravaginal
Intratubal
The report has provided a detailed breakup and analysis of the global artificial insemination market based on the type. This includes intrauterine, intracervical, intravaginal, and intratubal. According to the report, the intrauterine segment dominates the market.
AIH-Husband
AID-Donor
The report has provided a detailed breakup and analysis of the global artificial insemination market based on the source type. This includes AIH-husband and AID-donor.
Hospitals and Clinics
Fertility Centers
Others
The report has provided a detailed breakup and analysis of the global artificial insemination market based on the end use. This includes hospitals and clinics, fertility centers, and others. According to the report, the fertility centers segment spearheads the market.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. As per the report, North America dominates the market. Some of the factors accelerating the North America artificial insemination market include the surging awareness regarding the advantages of artificial insemination, the rising consumer per capita expenditure, and burgeoning healthcare expenditure.
The report has also provided a comprehensive analysis of the competitive landscape in the global artificial insemination market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Conceivex Inc., FUJIFILM Irvine Scientific Inc. (Fujifilm Holdings Corporation), Genea Limited, Genus plc, Hamilton Thorne Inc., Hi-Tech Solutions, Kitazato Corporation, Pride Angel, Rinovum Women's Health LLC, Rocket Medical plc, TenderNeeds Fertility LLC, Vitrolife AB, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.